Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 110902601000001115 | Cetraxal Plus | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 110902701000001113 | Cetraxal Plus (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cetraxal Plus | Is a | Trade family | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus | Has trade family group | Cetraxal | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) | Is a | True | Cetraxal Plus | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR